{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:32:09Z","timestamp":1791909129726,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["5 H30 MC00008-20-00"],"award-info":[{"award-number":["5 H30 MC00008-20-00"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 HL144457"],"award-info":[{"award-number":["P01 HL144457"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jtha.2026.02.010","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:45:11Z","timestamp":1772610311000},"page":"2656-2660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recommendation to adopt the type 1C VWD nomenclature into the classification of von Willebrand disease: communication from the ISTH Scientific and Standardisation Subcommittee on von Willebrand Factor"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8056-6116","authenticated-orcid":false,"given":"Christopher J.","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross I.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Haberichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.02.010_bib1","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/bjh.19385","article-title":"Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors\u2019 Organisation and the British Society for Haematology","volume":"204","author":"Platton","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.02.010_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.02.010_bib3","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.010_bib4","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand\u2019s Disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.02.010_bib5","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jtha.2024.05.006","article-title":"Application of genetic testing for the diagnosis of von Willebrand disease","volume":"22","author":"Seidizadeh","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.010_bib6","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2014-08-528398","article-title":"Diagnostic approach to von Willebrand disease","volume":"125","author":"Ng","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.02.010_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/bjh.16681","article-title":"New developments in von Willebrand disease","volume":"191","author":"Fogarty","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.02.010_bib8","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.02.010_bib9","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/bloodadvances.2020002038","article-title":"Low VWF: insights into pathogenesis, diagnosis, and clinical management","volume":"4","author":"O\u2019Donnell","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.02.010_bib10","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V66.4.796.796","article-title":"Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor","volume":"66","author":"Mannucci","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.02.010_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V99.1.180","article-title":"Reduced von Willebrand factor survival in type Vicenza von Willebrand disease","volume":"99","author":"Casonato","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.02.010_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/hae.14204","article-title":"How we diagnose 2M von Willebrand disease (VWD): Use of a strategic algorithmic approach to distinguish 2M VWD from other VWD types","volume":"27","author":"Favaloro","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.02.010_bib13","series-title":"Textbook of von Willebrand Disease","first-page":"109","author":"Christopherson","year":"2024"},{"key":"10.1016\/j.jtha.2026.02.010_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/hae.14970","article-title":"Diagnosis and treatment of von Willebrand disease in 2024 and beyond","volume":"30","author":"James","year":"2024","journal-title":"Haemoph : Off J World Fed Hemoph"},{"key":"10.1016\/j.jtha.2026.02.010_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/jth.15586","article-title":"Von Willebrand disease type 2M: Correlation between genotype and phenotype","volume":"20","author":"Maas","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.010_bib16","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1055\/s-0041-1726097","article-title":"Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological Mechanisms","volume":"47","author":"Woods","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.02.010_bib17","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/jth.13742","article-title":"Clinical and laboratory phenotype variability in type 2M von Willebrand disease","volume":"15","author":"Doruelo","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.010_bib18","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/bloodadvances.2022007216","article-title":"Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2","volume":"6","author":"Seidizadeh","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.02.010_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003038","article-title":"A Laboratory Phenotype\/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease","volume":"95","author":"Veyradier","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.jtha.2026.02.010_bib20","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1016\/S0021-9258(19)76501-6","article-title":"Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III","volume":"262","author":"Pareti","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.02.010_bib21","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1538-7836.2010.03869.x","article-title":"Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD","volume":"8","author":"Flood","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.02.010_bib22","article-title":"Standardization of von Willebrand Disease Nomenclature: Type 1C von Willebrand Disease and Type 2M (Platelet Binding Defect; Collagen Binding Defect)","author":"Haberichter","year":"2020","journal-title":"International Society of Thrombosis and Haemostasis: VWF SSC"},{"key":"10.1016\/j.jtha.2026.02.010_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.02.010_bib24","series-title":"Textbook of von Willebrand Disease","first-page":"143","author":"Janbain","year":"2024"},{"key":"10.1016\/j.jtha.2026.02.010_bib25","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2015-04-512731","article-title":"von Willebrand factor propeptide: biology and clinical utility","volume":"126","author":"Haberichter","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.02.010_bib26","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.02.010_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bjh.15565","article-title":"von Willebrand factor clearance - biological mechanisms and clinical significance","volume":"183","author":"O\u2019Sullivan","year":"2018","journal-title":"Br J Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:56:42Z","timestamp":1785880602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1538783626001273"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.02.010","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendation to adopt the type 1C VWD nomenclature into the classification of von Willebrand disease: communication from the ISTH Scientific and Standardisation Subcommittee on von Willebrand Factor","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}